Comparing digital and analog chest tube drainage systems in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the Thopaz digital chest tube drainage system compared to the traditional analog system in pediatric patients requiring chest tube placement for spontaneous pneumothorax or pulmonary resection. It is a single-site, prospective randomized controlled trial conducted at The Children's Hospital at OU Health. Participants will be randomized to receive either the digital or analog system, and various outcomes such as duration of chest tube drainage, length of hospital stay, and complications will be measured. The study aims to fill a gap in the literature regarding the benefits of digital drainage systems in a pediatric population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age≤17 years old
* requiring chest tube placement for spontaneous pneumothorax or pulmonary resection by a surgeon (or surgical trainee) at The Children's Hospital

Exclusion Criteria:

* age≥18-year-old
* chest tube placement by neonatologist or pediatrician,
* malignant pleural effusion
* re-operation or emergent operation
* pre-operative chemotherapy or radiation or history of chemotherapy or radiation within the past 12 months
* renal or hepatic failure
* neurological dysfunction
* empyema

Where it's running

• University of Oklahoma
  Oklahoma City, Oklahoma, United States Recruiting

Study contacts

• Principal investigator: Catherine Hunter, MD — University of Oklahoma
• Study coordinator: Catherine Hunter, MD
• Email: catherine-hunter@ouhsc.edu
• Phone: 2718001

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating reasons for longer hospital stays after lung surgery

  This study looks at why some patients stay in the hospital longer after lung surgery and aims to find ways to improve their recovery.

  Recruiting at 2 sites University Hospital, Ghent · Bruges and 1 other locations · NCT06638645

• Biopsy-site marker stiffness in breast cancer

  This observational study will see if the stiffness of biopsy-site markers relates to inflammation and potential spread in women with breast cancer.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT07833566

• Protoacoustic Imaging to See Radiation Delivery in Proton Therapy

  This study tests radioacoustic imaging with ultrasound to help doctors see where proton therapy is delivering radiation for liver and prostate cancer patients.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT07832617

• Modified FOLFIRINOX with Pentamidine in Advanced Pancreatic Cancer

  This study tests whether adding pentamidine to a modified FOLFIRINOX regimen helps people with advanced or metastatic pancreatic cancer.

  Recruiting Phase 1 University of Oklahoma · Oklahoma City, Oklahoma · NCT07829185

• Testing Alcohol Health Warning Labels for US Adults

  A randomized online study will test different warning statements about alcohol and breast cancer risk among adult US women who drink or are young non-drinkers to see which warnings are most convincing.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT07812545

• Testing warning labels on cannabis packaging to see what design helps people notice risks

  Researchers are testing different cannabis warning labels to see which designs make people notice health risks and think about their use more carefully.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT07701304

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.